Weiler et al., “Randomized, double blind, parallel groups, placebo-controlled study of efficacy and safety of Rynatan in the treatment of allergic rhinits using an acute model,” Annals of Allergy, vol. 64(1): 63-67 (1990). |
Goldberg et al., “Evaluation of a Prolonged Action Oral Antihistaminic Preparation as Treatment for Allergic Disorders,” Clinical Medicine, vol. 72(9): 1475-1479 (1965). |
TRIPLE TANNATE, Drug Launches 5/99. |
TUSSI-12, Drug Launches 3/99. |
TUSSI-12, Drug Launches 12/98. |
R-TANNATE, Drug Launches 8/98. |
TRIPLE TANNATE, Drug Launches. 1/98. |
ATROHIST, Drug Launches. 5/97. |
GELHIST, Drug Launches. 5/97. |
PHENATAN, Drug Launches 1/97. |
TRIOTANN, Drug Launches 12/95. |
TRI-TANNATE, Drug Launches 6/95. |
RICOBIN-D, Drug Launches 6/95. |
RICOBID, Drug Launches 6/95. |
QUAD-TUSS TANNATE, Drug Launches 4/95. |
TRI-TANNATE, Drug Launches 3/99. |
TRITAN, Drug Launches 9/96. |
TRI-NATAN, Drug Launches 11/93. |
R-TANNATE, Drug Launches 11/93. |
TRIN TUSS, Drug Launches 3/93. |
TANORAL, Drug Launches 4/92. |
HISTATUSS, Drug Launches 7/91. |
TRI-TANNATE, Drug Launches 9/87. |
TRI-TANNATE, Drug Launches 9/87. |
TANORAL, Drug Launches 4/92. |
“Robitussin et seq.” Physician's Desk Reference, 33rd Ed., 1979, pp. 1424-1425. |
Wilson and Grisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, Ninth Ed. 1991, pp. 423 & 425. |